ClinicalTrials.Veeva

Menu

A Study to Look at Antiepileptic Drug Levels While on Lamictal or Depakote With or Without an Oral Contraceptive

Beth Israel Lahey Health logo

Beth Israel Lahey Health

Status

Completed

Conditions

Epilepsy

Study type

Observational

Funder types

Other

Identifiers

NCT00296413
2005P000379

Details and patient eligibility

About

Some antiseizure medication levels are affected by hormones. This study is being done to determine if blood levels of lamotrigine or valproate are affected by the hormones in the birth control pill or the menstrual cycle itself.

Full description

Participants will be given informed consent and will be asked to have two blood draws at specific times of the menstrual cycle or if on a birth control pill, during the active and inactive pill phases.

Enrollment

48 estimated patients

Sex

Female

Ages

13 to 45 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Must be a female between 13-45 years of age
  • Must have a history of seizures
  • Must be taking either lamotrigine (Lamictal) or valproate (Depakote) with or without a birth control pill

Exclusion criteria

  • Must not be on antidepressant medication, tranquilizers, or other forms of hormonal therapy other than the birth control pill

Trial design

48 participants in 4 patient groups

1
Description:
Valproate monotherapy
2
Description:
Valproate monotherapy with combined oral contraceptive
3
Description:
Lamotrigine monotherapy
4
Description:
Lamotrigine monotherapy with combined oral contraceptive

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems